EDGAR Filing Documents for 0001181431-10-051769

Form 3 - Initial statement of beneficial ownership of securities:

SEC Accession No. 0001181431-10-051769

Filing Date

2010-10-22

Accepted

2010-10-22 16:58:45

Documents

Period of Report

2010-10-21

Document Format Files

Seq	Description	Document	Type	Size
1		rrd288503.html	3
1		rrd288503.xml	3	3092
2	LIMITED POWER OF ATTORNEY	rrd258659_292149.htm	EX-24.1	5954
	Complete submission text file	0001181431-10-051769.txt		10935

Mailing Address C/O AEGERION PHARMACEUTICALS CENTERPOINTE IV, 1140 ROUTE 22 EAST BRIDGEWATER NJ 08807

Business Address

Type: 3 | Act: 34 | File No.: 001-34921 | Film No.: 101137769

Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807

Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300

Aegerion Pharmaceuticals, Inc. (Issuer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations